GLOBAL ECOSYSTEM IN DRUG DISCOVERY
I. Biotechnology sector & Pharmaceutical industry
II. Intellectual Property and Strategy
III. Add Value & Unmet Need in Innovation
IV. Market Analysis Competitors in Development
V. Early Stage Licensing Agreements
VI. Public Funding for start-ups and spin-offs
VII. Early Market Access and Health Economics
VIII. Venture Funds and Late Stage Licensing

SCIENTIFIC AND REGULATORY DEVELOPMENT
I. Drug Discovery Process II. Target Product Profile (TPP)
III. Stakeholders in clinical and preclinical developments
IV. Preclinical and Clinical Development of Chemical compounds
V. Preclinical and Clinical Development of Biologic compounds
VI. Clinical Trial Design, Planification and Costs
VII. QXP’s and GMP’s during drug developments
VIII. Drug Registration Dossier for Approval FDA/EMA

PROFESIONAL AND PERSONAL DEVELOPMENT
I. Team Building
II. Leadership
III. Negotiation
IV. Management

BIOTECHNOLOGY BASED COMPANIES
I. Financial Statements
II. Financial Ratios and Analysis
III. Financial Management
IV. Debt Management
V. Project Management Fundamentals
VI. Public and Private Funding
VII. Venture Valuation and Financial Models
VIII. Early Market Access and Pricing
IX. Strategic Marketing vs Operational
X. Medical Marketing

VENTURE CAPITAL AND FUNDING
I. Private and Public Companies Valuation
II. Venture Financial Models
III. Capital Increase Strategy
IV. Due Diligence and Negotiations
V. Shareholders Agreement
VI. Exist Strategy and ROI
VII. Deal Structure and Milestones
VIII. Initial Public Offers IPO’s
IX. M&A vs Late Stage Licensing
X. Strategic alliances